No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Pharmaceuticals
DongKook Pharmaceutical Co., Ltd., established in Seoul, South Korea in 1968, operates as a pharmaceutical company with a broad presence both domestically and globally. Formerly known as UEC & Co., Ltd. until its rebranding in March 1982, the firm manufactures and distributes a diverse array of healthcare products. Its offerings include essential active pharmaceutical ingredients like propofol, streptokinase, and teicoplanin. The company also produces a wide range of finished drug forms such as disposable syringes, tablets, capsules, and topical ointments, in addition to various injectable solutions including small and large volume parenterals, and lyophilized medications. Specific branded injections like Teicon, Durakinase, and Lorelin Depot are also part of its portfolio. Furthermore, DongKook develops and supplies natural product derivatives, featuring black cohosh and magnolia extracts (marketed as ETIZM and TECA), alongside traditional herbal remedies. Its extensive inventory also encompasses general and prescription-based drugs, medical equipment, ethical and beauty products, and specific quasi-drugs, such as the lipossol hydrocare bandage. The company's market reach extends to roughly 40 nations, with substantial exports to regions including Japan, Europe, Central and South America, and India.
www.dkpharm.co.krNo one on the platform currently holds 086450.KQ.
No tracked institution reports a position in 086450.KQ as of their last filing.
No one on the platform has traded 086450.KQ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 11.0% | 10.4% | 13.3% | — | — | — |
| Rev. Growth % | 14.1% | 10.6% | ||||
| Profit Margin % | 7.1% | 7.5% | 9.5% | |||
| Free Cash Flow Margin % | 3.2% | 1.5% | 2.5% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $1.05T | +14.5% | $1890.33 | $1890.33–$1890.33 | — | 1 |
| 2027 | $1.19T | +13.3% | $2163.33 | $2163.33–$2163.33 | — | 1 |
| 2028 | $1.34T | +12.3% | $2516.33 | $2516.33–$2516.33 | — | 1 |
| 2029 | $1.48T | +10.9% | $0.00 | $0.00–$0.00 | — | 0 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 086450.KQDongKook Pharmaceutical Co., Ltd. | $20300.00 | -0.98% | $915.7B | — |
| 000640.KSDong-A Socio Holdings Co., Ltd. | $94400.00 | +1.83% | $635.6B | — |
| 001060.KSJW Pharmaceutical Corporation | $27100.00 | +0.00% | $625.8B | — |
| 001065.KSJW Pharmaceutical Corporation | $22350.00 | -0.22% | $394.3B | — |
| 003850.KSBoryung Corporation |
| $8590.00 |
| -7.44% |
| $725.7B |
| — |
| 019170.KSShinpoong Pharmaceutical Co., Ltd. | $9970.00 | -0.99% | $515.5B | — |
| 019175.KSShinpoong Pharmaceutical Co.,Ltd | $14580.00 | -3.76% | $386.3B | — |
Source: Financial Modeling Prep · peers by sector/industry